$0.06
▼ -21.0% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
Teva makes stalking horse bid for BioXcel assets
Overview
52-week range
$0.07
$4.29
0% of range
Avg surprise (last 3)
+15.6%
Avg reaction (last 2)
-4.5%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.49 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.54 | $-0.59 | +8.5% | +64.0% | -5.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-2.18 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-2.45 | $-2.30 | -6.5% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-1.50 | $-2.72 | +44.9% | — | -3.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-5.15 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.30 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-13.89 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.72 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.83 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.84 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $182,000 | $206,000 | — | $98,000 | $120,000 | $168,000 | — | $214,000 |
| Cost of revenue | $22,000 | $283,000 | — | $11,000 | $107,000 | $14,000 | — | $1M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-10M | $-10M | — | $-14M | $-16M | $-10M | — | $-15M |
| Net income | $-15M | $-13M | — | $-31M | $-19M | $-7M | — | $-14M |
| EPS (diluted) | $-0.49 | $-0.54 | — | $-2.18 | $-2.45 | $-1.50 | — | $-5.15 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $17M | $28M | $36M | $17M | $31M | $30M | $40M |
| Inventory | $483,000 | $500,000 | $722,000 | $459,000 | $506,000 | $642,000 | $679,000 | $2M |
| Total current assets | $29M | $34M | $45M | $44M | $25M | $38M | $37M | $48M |
| Total assets | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M |
| Long-term debt | $0 | $78M | $85M | $92M | $97M | $100M | $103M | $104M |
| Total liabilities | $144M | $140M | $140M | $134M | $133M | $129M | $131M | $135M |
| Total equity | $-115M | $-106M | $-95M | $-89M | $-108M | $-90M | $-93M | $-86M |
Implied volatility — last 90 days
No IV snapshots yet for BTAI.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.